Group 1288

Our Biologics Pipeline

Group 1290 (6)

Absci’s biologics pipeline reflects our differentiated capabilities in de novo antibody creation, multiparameter lead optimization, and reverse immunology. We’re developing a diversified portfolio of programs with a focus on cytokine biology as we scale our drug creation platform and strive to impact millions of lives.




Group 1284
Group 1290

How can our Integrated Drug Creation™ platform help you go from drug discovery to drug creation?

Group 1290 (2)
Group 1288